Skip to Main Content

Paper Details

Extracellular Matrix in Synthetic Hydrogel-Based Prostate Cancer Organoids Regulate Therapeutic Response to EZH2 and DRD2 Inhibitors.
Adv Mater
22
2022
-, AR, Adeno, CRPC, CRPC-, CRPC-NEPC, CRPC-NEPCs, DRD2, Dopamine, Dopamine Receptor D2, EZH2, NEPCs, Prostate Cancer, RNA, Synthetic Hydrogel-Based Prostate Cancer Organoids, androgen, androgen receptor, castration-resistant prostate cancer adenocarcinoma, mice, mobilized genes, neuroendocrine, neuroendocrine prostate cancer, neuroendocrine tumors, patient, patients, prostate cancer, synthetic hydrogel, tumor, tumors
Author NameAffiliation
Rohan BarejaEnglander Institute for Precision Medicine, Weill Cornell Medicine-New York-Presbyterian Hospital
Rohan BarejaInstitute for Computational Biomedicine
Michael SigourosEnglander Institute for Precision Medicine, Weill Cornell Medicine-New York-Presbyterian Hospital
Cynthia CheungEnglander Institute for Precision Medicine, Weill Cornell Medicine-New York-Presbyterian Hospital
David S Rickman
Joshua E AllenInc.
Loredana PucaEnglander Institute for Precision Medicine, Weill Cornell Medicine-New York-Presbyterian Hospital
Mark A RubinUniversity of Bern
Mark A RubinUniversity of Bern
Himisha BeltranDana Farber Cancer Institute, Harvard Medical School
Himisha BeltranDana Farber Cancer Institute, Harvard Medical School
Juan Miguel MosqueraEnglander Institute for Precision Medicine, Weill Cornell Medicine-New York-Presbyterian Hospital
Juan Miguel Mosquera
Juan Miguel MosqueraEnglander Institute for Precision Medicine, Weill Cornell Medicine-New York-Presbyterian Hospital
Juan Miguel Mosquera
Olivier ElementoEnglander Institute for Precision Medicine, Weill Cornell Medicine-New York-Presbyterian Hospital
Olivier ElementoInstitute for Computational Biomedicine
Olivier ElementoEnglander Institute for Precision Medicine, Weill Cornell Medicine-New York-Presbyterian Hospital
Olivier ElementoInstitute for Computational Biomedicine
  • 1 - 19

Datasets

Release 1.2